28 results
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
to that product or the manufacturing facility, including requiring recall or withdrawal of the product from the market or suspension of manufacturing … commercialize future products. Some of these events could be the basis for FDA action, including injunction, recall, seizure or total or partial
S-4/A
ufv9xwd
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
dt5leix3gbzc1
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.9
tbfq9yzobg64 l37pu7
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-10.1
6oi452aff1x7apebwnh
12 May 20
Current report (foreign)
12:04pm
6-K
EX-10.1
a0kmruvjjrgbq s8o97
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-10.1
0kcy 508xutd
17 May 19
Current report (foreign)
5:20pm
6-K
EX-1.1
twoiwun0
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am